PINZI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.761
AS - Asia 2.908
EU - Europa 2.201
SA - Sud America 494
AF - Africa 66
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.638
IT - Italia 932
SG - Singapore 892
CN - Cina 711
HK - Hong Kong 415
BR - Brasile 381
VN - Vietnam 353
GB - Regno Unito 328
SE - Svezia 255
DE - Germania 112
BD - Bangladesh 110
RU - Federazione Russa 104
FI - Finlandia 99
ID - Indonesia 96
KR - Corea 78
IN - India 61
CA - Canada 57
FR - Francia 57
NL - Olanda 56
AR - Argentina 42
UA - Ucraina 40
MX - Messico 39
TR - Turchia 38
BG - Bulgaria 34
LT - Lituania 34
ES - Italia 30
IQ - Iraq 26
JP - Giappone 23
BE - Belgio 21
PL - Polonia 21
EC - Ecuador 19
VE - Venezuela 18
ZA - Sudafrica 18
AT - Austria 16
IE - Irlanda 15
CO - Colombia 14
PK - Pakistan 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
KE - Kenya 9
PH - Filippine 9
SA - Arabia Saudita 8
CH - Svizzera 7
IR - Iran 7
MA - Marocco 7
TN - Tunisia 7
EG - Egitto 6
UY - Uruguay 6
CL - Cile 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HR - Croazia 4
IL - Israele 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
HN - Honduras 3
JM - Giamaica 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
Totale 10.424
Salva come PNG Salva come JPEG
Città #
Santa Clara 630
Ashburn 525
Singapore 463
Fairfield 406
Hong Kong 403
Chandler 288
San Jose 234
Hefei 199
Nyköping 182
Woodbridge 171
Council Bluffs 161
Modena 149
Beijing 146
Seattle 139
London 133
Houston 132
Ho Chi Minh City 126
Cambridge 120
Wilmington 112
Southend 109
Milan 98
Los Angeles 94
Ann Arbor 88
Hanoi 87
Helsinki 82
Bologna 80
The Dalles 80
Seoul 77
Chicago 74
Jakarta 74
New York 72
San Diego 44
Princeton 41
Dearborn 38
Shanghai 36
Jacksonville 35
São Paulo 34
Reggio Emilia 33
Rome 33
Sofia 32
Parma 30
Buffalo 28
Lauterbourg 28
Salt Lake City 28
Dallas 27
Orem 24
Munich 23
Moscow 20
Tampa 20
Brussels 19
Tokyo 19
Elk Grove Village 18
Naples 18
Toronto 18
Warsaw 17
Boardman 16
Nuremberg 16
Denver 15
Eugene 15
Haiphong 15
Mexico City 15
Kent 13
Poplar 13
Redondo Beach 13
Rio de Janeiro 13
Izmir 12
Mumbai 12
Phoenix 12
Biên Hòa 11
Formigine 11
Frankfurt am Main 11
Lappeenranta 11
Stockholm 11
Amsterdam 10
Brooklyn 10
Chennai 10
Da Nang 10
Dublin 10
Guangzhou 10
Johannesburg 10
Kilburn 10
Tashkent 10
Vienna 10
Atlanta 9
Baghdad 9
Boston 9
Des Moines 9
Frattamaggiore 9
Miano 9
Montreal 9
Nairobi 9
Turin 9
Curitiba 8
Meana Sardo 8
Paris 8
Redwood City 8
Brasília 7
Brescia 7
Dhaka 7
Manchester 7
Totale 6.873
Salva come PNG Salva come JPEG
Nome #
An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators 374
On the integration of in silico drug design methods for drug repurposing 313
Selection of protein conformations for structure-based polypharmacology studies 309
Molecular docking: Shifting paradigms in drug discovery 306
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 305
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L. 305
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease 285
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank 284
Identification of small-molecule EGFR allosteric inhibitors by high-Throughput docking 283
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 281
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 271
Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors 270
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models 260
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 256
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 250
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90 249
Computational polypharmacology comes of age 239
LigAdvisor: A versatile and user-friendly web-platform for drug design 229
2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B 222
Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90) 221
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 220
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity 212
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies 202
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies 195
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing 183
Refinement and rescoring of virtual screening results 183
How drug repurposing can advance drug discovery: challenges and opportunities 179
Virtual screening for dual Hsp90/B-Raf inhibitors 177
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 175
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA) 174
Repositioning natural products in drug discovery 171
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase 167
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers 166
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 165
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 165
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 155
Development and application of LigAdvisor, a user-friendly web-platform for polypharmacology and drug repurposing 154
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B 144
Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction 142
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines 136
On the development of B-Raf inhibitors acting through innovative mechanisms 136
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 134
LigAdvisor: a web server to perform in silico explorations on crystallographic ligands and known drugs for polypharmacology and drug repurposing. 119
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 117
LigAdvisor: a web platform designed for charting novel polypharmacology and drug repurposing routes from crystallographic ligands and known drugs 116
Exploring Biological Targets of Magnolol and Honokiol and their Nature-Inspired Synthetic Derivatives: In Silico Identification and Experimental Validation of Estrogen Receptors 113
Targeting the allosteric sites of the B-Raf protein kinase through an in silico approach 109
Rational design of dual inhibitors of Hsp90 and B-Raf as a novel pharmacological approach against melanomas 104
Trends and Applications in Computationally Driven Drug Repurposing 103
Polypharmacology predictions in the Protein Data Bank 95
Unveiling target associations for polypharmacology from analysis of crystallographic ligands in the Protein Data Bank 95
Tackling polypharmacology and drug repurposing with the LigAdvisor webserver. 95
Rational design of dual inhibitors of Hsp90 and Braf as a novel pharmacological approach against melanomas 87
Predicting drug polypharmacology using structural databases 83
Improving Machine Learning Classification Predictions through SHAP and Features Analysis Interpretation 14
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 13
Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models 12
Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies 10
Design, synthesis, and biological evaluation of chalcone derivatives as selective Monoamine Oxidase-B inhibitors with potential neuroprotective effects 7
Totale 10.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022807 67 41 48 52 19 36 49 61 88 54 192 100
2022/2023900 105 129 70 84 87 107 37 96 107 25 36 17
2023/2024772 28 44 52 73 138 55 98 111 17 14 48 94
2024/20252.435 63 19 66 185 482 309 116 171 203 272 239 310
2025/20264.027 266 169 327 541 582 207 479 181 415 374 331 155
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 10.539